Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | 3 | IL-8 | 472.0 | 61 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-8 | 625.0 | 69 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-8 | 1245.0 | 69 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-8 | 944.0 | 96 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL-8 | 396.0 | 63 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | IL-8 | 279.0 | 87 | ||||
N2586 | 3 | IL-8 | 1298.0 | 82 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | IL-8 | 813.5 | 104 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | IL-8 | 1053.0 | 59 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | IL-8 | 1509.0 | 77 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | IL-8 | 1061.0 | 75 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL-8 | 717.5 | 68 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | IL-8 | 732.0 | 54 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | IL-8 | 1435.0 | 65 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 689.0 | 58 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 1137.5 | 72 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 2708.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 1595.0 | 48 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 477.0 | 65 | |
N2586 | IL-17A | 100 | ng/mL | 3 | IL-8 | 2041.5 | 82 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 1389.0 | 89 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 553.0 | 98 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 2236.5 | 70 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 2323.0 | 59 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL-8 | 990.0 | 63 |